MX354966B - Composiciones de accion prolongada. - Google Patents

Composiciones de accion prolongada.

Info

Publication number
MX354966B
MX354966B MX2014010957A MX2014010957A MX354966B MX 354966 B MX354966 B MX 354966B MX 2014010957 A MX2014010957 A MX 2014010957A MX 2014010957 A MX2014010957 A MX 2014010957A MX 354966 B MX354966 B MX 354966B
Authority
MX
Mexico
Prior art keywords
long acting
acting compositions
composition includes
long
composition
Prior art date
Application number
MX2014010957A
Other languages
English (en)
Other versions
MX2014010957A (es
Inventor
Nanjan Karthigeyan
Al Alawi Fadil
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49161532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX354966(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of MX2014010957A publication Critical patent/MX2014010957A/es
Publication of MX354966B publication Critical patent/MX354966B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención hace referencia a una composición de acción prolongada para tratar un animal que requiere tratamiento y que incluye una cantidad terapéuticamente eficaz de un agente bioactivo, caracterizada porque la composición incluye un portador no acuoso y un sistema solvente que comprende aceite de ricino y al menos una amida cíclica.
MX2014010957A 2012-03-13 2013-03-13 Composiciones de accion prolongada. MX354966B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ59875712 2012-03-13
PCT/NZ2013/000036 WO2013137748A1 (en) 2012-03-13 2013-03-13 Long acting compositions

Publications (2)

Publication Number Publication Date
MX2014010957A MX2014010957A (es) 2014-10-13
MX354966B true MX354966B (es) 2018-03-27

Family

ID=49161532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010957A MX354966B (es) 2012-03-13 2013-03-13 Composiciones de accion prolongada.

Country Status (20)

Country Link
US (1) US9616044B2 (es)
EP (1) EP2825154A4 (es)
JP (1) JP6273252B2 (es)
KR (1) KR20140136005A (es)
CN (1) CN104168886A (es)
AU (1) AU2013201479C1 (es)
CA (1) CA2867079A1 (es)
CL (1) CL2014002401A1 (es)
CO (1) CO7071132A2 (es)
CR (1) CR20140423A (es)
DO (1) DOP2014000207A (es)
IL (1) IL234597A0 (es)
MX (1) MX354966B (es)
NI (1) NI201400106A (es)
PE (1) PE20142279A1 (es)
PH (1) PH12014502016B1 (es)
RU (1) RU2014141088A (es)
SV (1) SV2014004804A (es)
WO (1) WO2013137748A1 (es)
ZA (1) ZA201406753B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
ES2131515T3 (es) * 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US6013636A (en) 1995-09-25 2000-01-11 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6998131B2 (en) * 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
GB9815801D0 (en) * 1998-07-21 1998-09-16 Merck & Co Inc Liquid polymeric compositions for controlled released bioactive substances
CN1130990C (zh) 1999-11-02 2003-12-17 王毅远 一种纯天然方便食品及其制造方法
US6340672B1 (en) 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AU781682B2 (en) 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
CN1383821A (zh) 2001-03-16 2002-12-11 王玉万 一种含丙硫苯咪唑亚砜或其盐类的兽用注射剂
AU2002100152B4 (en) * 2002-02-28 2002-04-11 Jurox Pty Ltd Parasiticide composition
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
CN1490009A (zh) * 2002-10-17 2004-04-21 王玉万 含抗球虫药物的缓释注射剂
ATE467352T1 (de) * 2003-05-19 2010-05-15 Nippon Soda Co Insektizide zusammensetzung
NZ535644A (en) 2003-07-25 2007-05-31 Ashmont Holdings Ltd Anthelmintic formulations
CN1293921C (zh) 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
TR200601608T1 (tr) 2003-10-17 2006-12-21 Akzo Nobel N.V Bir avermektin kombinasyonu içeren uzun süre etkili bileşimler.
AU2005100403B4 (en) * 2005-05-13 2005-09-01 Jurox Pty Ltd Parasiticide Composition
BRPI0800259A2 (pt) * 2008-02-27 2011-05-31 Noxon Do Brasil Quimica E Farmaceutica Ltda formulações veterinárias compreendendo lactonas macrocìclicas e minerais, seus usos na preparação de produtos veterinários e métodos de ganho de produtividade e tratamento e/ou profilaxia de doenças causadas por agentes biológicos nocivos à saúde animal
US20100022469A1 (en) 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
JP2012517994A (ja) 2009-02-16 2012-08-09 ファイザー・インク 高投与量ドラメクチン製剤
CN101703776B (zh) * 2009-09-28 2012-07-11 洛阳惠中兽药有限公司 一种抗感染剂长效注射液的制备方法
BRPI1001224A2 (pt) 2010-04-07 2011-03-15 Clarion Biociencias Ltda processo de fabricação de formulação injetável a base de fluazuron associado a avermectinas para o controle e prevenção de endo e ectoparasitas em animais domésticos
NZ611474A (en) * 2010-12-27 2015-08-28 Intervet Int Bv Topical localized isoxazoline formulation comprising glycofurol

Also Published As

Publication number Publication date
AU2013201479C1 (en) 2017-11-09
JP2015509978A (ja) 2015-04-02
US20150038565A1 (en) 2015-02-05
DOP2014000207A (es) 2014-11-30
CR20140423A (es) 2014-10-20
JP6273252B2 (ja) 2018-01-31
RU2014141088A (ru) 2016-05-10
WO2013137748A1 (en) 2013-09-19
CO7071132A2 (es) 2014-09-30
KR20140136005A (ko) 2014-11-27
IL234597A0 (en) 2014-11-30
PH12014502016A1 (en) 2014-11-24
MX2014010957A (es) 2014-10-13
EP2825154A1 (en) 2015-01-21
SV2014004804A (es) 2017-04-20
AU2013201479A1 (en) 2013-10-03
AU2013201479B2 (en) 2015-07-02
PH12014502016B1 (en) 2014-11-24
EP2825154A4 (en) 2015-11-11
CN104168886A (zh) 2014-11-26
CA2867079A1 (en) 2013-09-19
PE20142279A1 (es) 2015-01-25
ZA201406753B (en) 2015-12-23
NI201400106A (es) 2015-01-14
US9616044B2 (en) 2017-04-11
CL2014002401A1 (es) 2015-04-17

Similar Documents

Publication Publication Date Title
MY172926A (en) Tetrahydropyrazolopyrimidine compounds
MX356368B (es) Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
SG11201601363YA (en) Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
IN2015DN03029A (es)
EP2906547A4 (en) COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE HYDROTROPE AND AT LEAST ONE ACTIVE COMPOUND
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EP2903627A4 (en) NON-IRRITANT LUBRICATING COMPOSITIONS WITH ACTIVE SENSORY AGENTS
JO3154B1 (ar) عوامل مضادة لـ trpv4
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
MX2016004540A (es) Tiazolopirimidinonas como moduladores de la actividad de receptores de n-metil-d-aspartato (nmda).
HK1210825A1 (en) Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
MX2016001138A (es) Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo.
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
EP3061448A4 (en) Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
EP3037091A4 (en) Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma
EP2910246A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER WITH ENOBLOCK AS AN ACTIVE SUBSTANCE
MX359955B (es) Formulación de aroma y fragancia (iii).
EP2886112A4 (en) COMPOSITION CONTAINING AS ACTIVE INGREDIENT OF S-ALLYL-L-CYSTEINE FOR PREVENTING OR TREATING OCULAR DISEASES, AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME
PH12014502016B1 (en) Long acting compositions
MX2014014816A (es) Composicion farmaceutica para tratar inflamacion y dolor.
MX2014013495A (es) 5-halogenopirazol bifenilcarboxamidas.
MX2016003763A (es) Terapia de combinacion con laquinimod para tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
FG Grant or registration